XFOR (XFOR) Stock Price & Analysis
XFOR (XFOR) rose 0.00% to USD 4.04 as of September 8, 2026 at 06:54 UTC, according to Nexqual real-time market data.
XFOR last closed at USD 4.04; the session ranged USD 4–4.08 on volume of 168,162 shares. Market capitalization is —, with a 52-week range of USD 2.8–4.83 (NCM). Source: Nexqual, September 8, 2026 at 06:54 UTC.
Key Statistics (as of September 8, 2026 at 06:54 UTC)
| Price | USD 4.04 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 4.04 |
| Open | USD 4.04 |
| Day Range | USD 4 – 4.08 |
| 52-Week Range | USD 2.8 – 4.83 |
| Volume | 168,162 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (XFOR)
Nexqual's technical model rates XFOR "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 06:54 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 51.2 (neutral) |
| vs SMA50 | Below (USD 4.08) |
| MACD | -0.02 (negative) |
From XFOR's Latest SEC 10-K Filing (filed 2026-03-17)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| OVID | Ovid Therapeutics Inc. | USD 2.8 | ▲ 3.32% |
| PDSB | PDS Biotechnology Corporation | USD 0.22 | ▲ 3.77% |
| TRVI | Trevi Therapeutics, Inc. | USD 17.26 | ▲ 1.23% |
| VRCA | Verrica Pharmaceuticals Inc. | USD 5.3 | ▼ 1.67% |
| MREO | Mereo BioPharma Group plc | USD 0.25 | ▼ 6.37% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:54 UTC. This page is informational and not investment advice.